Skip to content

Clinical trials

Completed Phase 3 Disorders of Excessive Somnolence trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disorders of Excessive Somnolence Phase: Phase 3 Status: Completed Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20048
20051
20081
20093
20102
20113
20131
20163
20201
20212
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cephalon10
Bioprojet9
Avadel2
Axsome Therapeutics, Inc.2
Citrine Medicine Limited1
Eileen R. Chasens1
Harmony Biosciences Management, Inc.1
Ignis Therapeutics (Suzhou) Limited1
Jazz Pharmaceuticals1
Orphan Medical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disorders of Excessive Somnolence30
Narcolepsy16
Cataplexy12
Sleep Apnea, Obstructive11
Sleep Wake Disorders6
Chronobiology Disorders3
Sleep Disorders, Circadian Rhythm3
Sleep Apnea Syndromes2
Alzheimer Disease1
Cognitive Dysfunction1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.